Trevi Therapeutics Inc (TRVI)

Finanzdaten der Trevi Therapeutics Inc-Aktie (TRVI)

*Alle Zahlen in Millionen

Enddatum des Zeitraums	2026-06-30	2026-03-31	2025-12-31	2025-09-30	2025-06-30
Periodenlänge	3 Monate	3 Monate	3 Monate	3 Monate	3 Monate
	37.53%20.51	14.91	10.22	13.92	13.72
Research and Development	52.42%15.15	9.94	6.19	10.09	9.39
Operating Income/Loss	37.53%-20.51	-14.91	-10.22	-13.92	-13.72
Nonoperating Income/Loss	58.41%2.69	1.70	1.89	2.10	1.40
Income/Loss From Continuing Operations Before Tax	34.85%-17.82	-13.21	-8.33	-11.82	-12.32
Income Tax Expense/Benefit	5.00%-0.02	-0.02	-0.02	-0.02	-0.02
	34.91%-17.80	-13.19	-8.32	-11.80	-12.30
Attributable To Parent	34.91%-17.80	-13.19	-8.32	-11.80	-12.30
Basic Average Shares	7.56%156.60	145.59	-	145.10	130.35
Diluted Average Shares	7.56%156.60	145.59	-	145.10	130.35
Basic Earnings Per Share	22.22%-0.11	-0.09	-	-0.08	-0.09
Diluted Earnings Per Share	22.22%-0.11	-0.09	-	-0.08	-0.09